24 January 2007 12:06 [Source: ICIS news]
LONDON (ICIS news)--Johnson Matthey expects underlying full year growth in earnings per share (EPS) to better the 9% achieved in the first half, chief executive Neil Carson said on Wednesday.
The pharmaceutical materials business is also ahead of last year, he added, with continued recovery in the
The full year EPS growth estimate excludes profits from the disposal of the ceramics division announced in December. Underlying EPS growth in the 2005/06 financial year was 9%.
Johnson Matthey expects to sell the ceramics business for €226m ($294m) in cash and use the proceeds to buy back shares and fund bolt-on acquisitions, Carson told an analysts briefing. The disposal, due to be completed on 28 February, will be slightly dilutive to earnings this year, he added.
Johnson Matthey’s shares rose sharply in value in mid January on stronger investor interest. The shares were at 1503p at 11:29GMT on Wednesday, up 1.5% on the Tuesday close.
($1 = €0.77/£0.51)
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
|ICIS Global Petrochemical Index (IPEX). Download the free tabular data and a chart of the historical index|